Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shared coagulotoxins from Pseudonaja venoms, primarily represented by the Pseutarin C-like prothrombin activators, are potent enzymatic complexes that mimic the human prothrombinase complex. These toxins are composed of two subunits structurally and functionally analogous to mammalian blood coagulation Factor Xa and Factor Va. Their primary biological function is the rapid and calcium-independent conversion of prothrombin into thrombin, which leads to massive fibrinogen consumption and the formation of microthrombi. In the context of human envenomation, this activity results in venom-induced consumption coagulopathy (VICC), a life-threatening condition characterized by non-clottable blood and a high risk of internal bleeding. These coagulotoxins are the primary therapeutic targets for brown snake antivenoms, which neutralize the enzymatic activity to restore normal hemostasis. Beyond toxicology, these molecules serve as significant models for studying the assembly and regulation of the mammalian coagulation cascade.
Antivenoms contain specific antibodies (F(ab')2 or IgG) that bind to the prothrombin activator complex, neutralizing its enzymatic activity and preventing the conversion of prothrombin to thrombin.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudonaja prothrombin activator (PPA).